Neuronetics, Inc. STIM
We take great care to ensure that the data presented and summarized in this overview for Neuronetics, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding STIM
View all-
Archon Capital Management LLC Seattle, WA2.47MShares$1.81 Million3.67% of portfolio
-
Cannell Capital LLC Alta, WY2.38MShares$1.74 Million1.07% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.74MShares$1.27 Million1.44% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.3MShares$948,9370.0% of portfolio
-
First Washington Corp Seattle, WA1.27MShares$930,4140.89% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY1.19MShares$871,4070.02% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.14MShares$835,2890.0% of portfolio
-
First Eagle Investment Management, LLC1.04MShares$758,4760.0% of portfolio
-
Parian Global Management LP Pound Ridge, NY830KShares$606,0998.59% of portfolio
-
G2 Investment Partners Management LLC New York, NY681KShares$497,4660.36% of portfolio
Latest Institutional Activity in STIM
Top Purchases
Top Sells
About STIM
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Insider Transactions at STIM
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 12
2024
|
Robert Cascella |
BUY
Open market or private purchase
|
Direct |
100,000
+18.08%
|
$0
$0.75 P/Share
|
|
Sep 05
2024
|
Glenn P Muir |
BUY
Open market or private purchase
|
Direct |
25,000
+7.94%
|
$0
$0.8 P/Share
|
|
Aug 29
2024
|
Glenn P Muir |
BUY
Open market or private purchase
|
Direct |
12,224
+4.41%
|
$0
$0.85 P/Share
|
|
Aug 28
2024
|
Glenn P Muir |
BUY
Open market or private purchase
|
Direct |
12,776
+4.81%
|
$0
$0.85 P/Share
|
|
Aug 20
2024
|
Glenn P Muir |
BUY
Open market or private purchase
|
Direct |
25,000
+9.44%
|
$25,000
$1.0 P/Share
|
|
Aug 19
2024
|
Robert Cascella |
BUY
Open market or private purchase
|
Direct |
4,000
+1.12%
|
$4,000
$1.14 P/Share
|
|
Aug 16
2024
|
Robert Cascella |
BUY
Open market or private purchase
|
Direct |
35,000
+9.11%
|
$35,000
$1.06 P/Share
|
|
Aug 15
2024
|
Robert Cascella |
BUY
Open market or private purchase
|
Direct |
35,000
+10.03%
|
$0
$0.88 P/Share
|
|
Aug 14
2024
|
Glenn P Muir |
BUY
Open market or private purchase
|
Direct |
25,171
+10.49%
|
$0
$0.75 P/Share
|
|
Aug 14
2024
|
Robert Cascella |
BUY
Open market or private purchase
|
Direct |
35,000
+11.14%
|
$0
$0.79 P/Share
|
|
Jul 18
2024
|
Keith J Sullivan President and CEO |
SELL
Open market or private sale
|
Direct |
24,162
-1.79%
|
$24,162
$1.9 P/Share
|
|
Jul 17
2024
|
Keith J Sullivan President and CEO |
SELL
Open market or private sale
|
Direct |
11,687
-0.86%
|
$11,687
$1.97 P/Share
|
|
Jul 16
2024
|
Keith J Sullivan President and CEO |
SELL
Open market or private sale
|
Direct |
12,075
-0.88%
|
$12,075
$1.91 P/Share
|
|
Jun 06
2024
|
Robert Cascella |
BUY
Open market or private purchase
|
Direct |
50,000
+17.0%
|
$100,000
$2.05 P/Share
|
|
May 30
2024
|
Robert Cascella |
BUY
Grant, award, or other acquisition
|
Direct |
31,250
+13.87%
|
-
|
|
May 30
2024
|
Glenn P Muir |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+11.65%
|
-
|
|
May 30
2024
|
Megan Rosengarten |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+18.4%
|
-
|
|
May 30
2024
|
Sheryl L Conley |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+15.16%
|
-
|
|
Feb 29
2024
|
Stephen Furlong EVP, CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+2.92%
|
-
|
|
Feb 29
2024
|
William Andrew Macan EVP, GC, CCO and CS |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+3.58%
|
-
|
Last 12 Months Summary
| Grant, award, or other acquisition | 626K shares |
|---|---|
| Open market or private purchase | 359K shares |
| Open market or private sale | 286K shares |
|---|